Thyroid hormone levels in patients with bipolar... - Thyroid UK

Thyroid UK

142,582 members167,964 posts

Thyroid hormone levels in patients with bipolar disorder: a systematic review and meta-analysis.

helvella profile image
helvellaAdministrator
3 Replies

Bipolar has been frequently mentioned on the forum. I think many suspect (or are sure) there are links between bipolar and thyroid hormones.

This paper, whilst a meta-analysis, seems to confirm links. Which is unlikely to surprise many.

Thyroid hormone levels in patients with bipolar disorder: a systematic review and meta-analysis.

Liu S 1, 2 , Chen X 2 , Li X 2 , Tian L 1, 2

BMC Endocrine Disorders, 18 Nov 2024, 24(1):248

doi.org/10.1186/s12902-024-... PMID: 39551764 PMCID: PMC11572511

Abstract

Purpose

To investigate the difference in blood (serum/plasma) thyroid hormone (TH) levels, including thyroid-stimulating hormone (TSH), thyroxine (T4), triiodothyronine (T3), free thyroxine (FT4), and free triiodothyronine (FT3), in bipolar disorder (BD) during different mood episodes (depression and mania) compared with healthy control (HC) and between manic episodes (BD-M) and depressive episodes (BD-D).

Methods

As of September 1, 2024, the electronic databases PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure, Chinese Biomedical Literature Database, China Science and Technology Journal Database, Wanfang Database, and Clinical Trials. Gov were systematically searched with no language limitations. Standardized mean differences (SMD) with 95% confidence interval (CI) were summarized using a random effects model. The chi-squared-based Q test and the I2 test assessed the size of heterogeneity.

Results

The 21 studies included a total of 3696 participants, Of the 2942 BD patients, 1583 were in depressive episodes 1359 were in manic episodes. The status of measuring blood TH levels included 2 studies in plasma and 19 in serum. Combined with the results of the sensitivity analyses, we obtained the following relatively reliable results: serum T3 (SMD: -0.63, 95%CI: -1.09 to -0.17) and FT3 (SMD: -0.42, 95%CI: -0.83 to -0.00) levels decreased significantly in BD-D compared to HC; serum T3 (SMD: -0.91, 95%CI: -1.49 to -0.32) levels decreased significantly and serum FT4 (SMD: 0.37, 95%CI: 0.14 to 0.60) levels increased significantly in BD-M than in HC; serum T3 (SMD: 0.87, 95%CI: 0.24 to 1.49) and FT3 (SMD: 0.27, 95%CI: 0.13 to 0.42) levels demonstrated a significant elevation in BD-M compared to BD-D. In the group of euthyroidism, apart from serum FT4 (SMD: 0.21, 95%CI: -0.15 to 0.58) levels showed no significant difference between BD-M and HC, other results above remained consistent.

Conclusion

Serum T3 and FT3 levels decreased significantly in BD-D compared to HC. Serum T3 levels decreased significantly and serum FT4 levels increased significantly in BD-M compared to HC. Serum T3 and FT3 levels increased significantly in BD-M than in BD-D. The temporality of changes in TH levels and BD progression demands further longitudinal studies to illustrate.

Open access here:

europepmc.org/article/MED/3...

Written by
helvella profile image
helvella
Administrator
To view profiles and participate in discussions please or .
Read more about...
3 Replies
arTistapple profile image
arTistapple

Very interesting. I like the way they separated the manic and depression phases. As you say not a surprising outcome to many and affirming our own observations re: issues/hyper/hypo/Hashimotos.

I don’t know enough about Graves.

helvella profile image
helvellaAdministrator

Exclusion criteria were as follows: (1) reviews, conference abstracts, letters, and other non-primary studies; (2) non-human research, such as animal experiments; (3) the object of studies accompanied by other mental illness (such as schizophrenia); (4) rapid cycling BD; (5) studies during pregnancy or lactation; (6) treatment-induced changes in TH levels, such as lithium; (7) data or full text was not available.

HandS profile image
HandS

Thank you for sharing this. My experience of supporting my adult daughter in both in patient and community mental health settings tells me that MH ‘treatment’ has never left the dark ages.

When I query physical symptoms in relation to their prescribed meds I get told “we’re not medical”.

Also, it appears to be standard practice that MH diagnoses can be changed to suit the drug of the day.

I’ve had 20 years of trying to make sense of anything the MH profession does or says. I think many ‘medical’ doctors experience the same feeling.

Will they ever join the dots 🤷‍♂️

Not what you're looking for?

You may also like...

Effect of thyroid dysfunction on N-terminal pro-B-type natriuretic peptide levels: A systematic review and meta-analysis

Papers regarding the impact of inappropriate thyroid hormone levels keep coming out. It would...
helvella profile image
Administrator

Thyroid hormone homeostasis in levothyroxine-treated patients: Findings from ELSA-Brasil

From paper Antonio C Bianco has posted on Twitter about this new paper (of which he is a listed...
helvella profile image
Administrator

Efficacy and Safety of Once Weekly Thyroxine as Compared to Daily Thyroxine in Managing Primary Hypothyroidism: A Systematic Review +

Over the years there have been many mentions of the possibility of once-a-week dosing with...
helvella profile image
Administrator

Association of Thyroid Function with Suicidal Behavior: A Systematic Review and Meta-Analysis

It tears hearts to read of medics saying that TSH is too low, and allowing T4 and T3 levels to be...
helvella profile image
Administrator

Systemic Thyroid Hormone Status During Levothyroxine Therapy In Hypothyroidism: A Systematic Review and Meta-Analysis

Evidence of the need for T3, in at least some hypothyroid patients, seems to be pouring in these...
helvella profile image
Administrator